Rozanolixizumab
Rozanolixizumab (UCB7665), a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P), is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases[1].
Product Specifications
CAS Number
1584645-37-3
Product Name Alternative
UCB7665
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rozanolixizumab.html
Purity
99.40
Solubility
H2O
Smiles
[Rozanolixizumab]
Molecular Weight
(145.242 kDa)
References & Citations
[1]Smith B, et al. Generation and characterization of a high affinity anti-human FcRn antibody, rozanolixizumab, and the effects of different molecular formats on the reduction of plasma IgG concentration. MAbs. 2018;10 (7) :1111-1130.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
IBCTNAPARN6HISLY10UG 10 µg
Bacteria-Derived SNAP-alpha Recombinant Protein N-6His Tag Lyophilized 10ug
Sign In for Pricing
View Details